Iron and Acinetobacter baumannii Biofilm formation

Pathogens

Volumn 3, Issue 3, 2014, Pages 704-719

  Gentile, Valentina ^a   Frangipani, Emanuela ^a   Bonchi, Carlo ^a   Minandri, Fabrizia ^a   Runci, Federica ^a   Visca, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

Acinetobacter baumannii; Biofilm; Chelator; Deferasirox; Deferiprone; Deferoxamine; Dipyridyl; Iron; Transferring

Indexed keywords

BETA GALACTOSIDASE; CHELATING AGENT; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; IRON; TRANSFERRIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIUM ISOLATE; BIOFILM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; EPIFLUORESCENCE MICROSCOPY; GROWTH INHIBITION; IRON CHELATION; IRON METABOLISM; IRON RESTRICTION; MICROTITER PLATE ASSAY; NONHUMAN; PLANKTON; SPECTROPHOTOMETRY;

EID: 84924946668     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens3030704     Document Type: Article

References (50)

1. Antunes, L.C.; Visca, P.; Towner, K.J. Acinetobacter baumannii: Evolution of a global pathogen. Pathog. Dis. 2014, 71, 292-301.
2. Falagas, M.E.; Bliziotis, I.A.; Siempos, I.I. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies. Crit. Care 2006, 10, R48.
3. Dijkshoorn, L.; Nemec, A.; Seifert, H. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5, 939-951.
4. Eveillard, M.; Kempf, M.; Belmonte, O.; Pailhoriès, H.; Joly-Guillou, M.L. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int. J. Infect. Dis. 2013, 17, e802-e805.
5. Endimiani, A.; Hujer, K.M.; Hujer, A.M.; Bertschy, I.; Rossano, A.; Koch, C.; Gerber, V.; Francey, T.; Bonomo, R.A.; Perreten, V. Acinetobacter baumannii isolates from pets and horses in Switzerland: Molecular characterization and clinical data. J. Antimicrob. Chemother. 2011, 66, 2248-2254.
6. Zarrilli, R.; Pournaras, S.; Giannouli, M.; Tsakris, A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 2013, 41, 11-19.
7. Durante-Mangoni, E.; Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011, 6, 407-422.
8. Neonakis, I.K.; Spandidos, D.A.; Petinaki, E. Confronting multidrug-resistant Acinetobacter baumannii: A review. Int. J. Antimicrob. Agents 2011, 37, 102-109.
9. García-Quintanilla, M.; Pulido, M.R.; López-Rojas, R.; Pachón, J.; McConnell, M.J. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol. 2013, 21, 157-163.
10. Jawad, A.; Seifert, H.; Snelling, A.M.; Heritage, J.; Hawkey, P.M. Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 1998, 36, 1938-1941.
11. Antunes, L.C.; Imperi, F.; Carattoli, A.; Visca, P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 2011, 6, e22674.
12. Giannouli, M.; Antunes, L.C.; Marchetti, V.; Triassi, M.; Visca, P.; Zarrilli, R. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect. Dis. 2013, 13, 282.
13. Gaddy, J.A.; Actis, L.A. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009, 4, 273-278.
14. Longo, F.; Vuotto, C.; Donelli, G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014, 37, 119-127.
15. Rodríguez-Baño, J.; Martí, S.; Soto, S.; Fernández-Cuenca, F.; Cisneros, J.M.; Pachón, J.; Pascual, A.; Martínez-Martínez, L.; McQueary, C.; Actis, L.A., et al. Spanish Group for the Study of Nosocomial Infections (GEIH). Biofilm formation in Acinetobacter baumannii: Associated features and clinical implications. Clin. Microbiol. Infect. 2008, 14, 276-278.
16. Lee, H.W.; Koh, Y.M.; Kim, J.; Lee, J.C.; Lee, Y.C.; Seol, S.Y.; Cho, D.T.; Kim, J. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 2008, 14, 49-54.
17. Wroblewska, M.M.; Sawicka-Grzelak, A.; Marchel, H.; Luczak, M.; Sivan, A. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals. FEMS Immunol. Med. Microbiol. 2008, 53, 140-144.
18. McQueary, C.N.; Actis, L.A. Acinetobacter baumannii biofilms: Variations among strains and correlations with other cell properties. J. Microbiol. 2011, 49, 243-250.
19. Tomaras, A.P.; Dorsey, C.W.; Edelmann, R.E.; Actis, L.A. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system. Microbiology 2003, 149, 3473-3484.
20. Weinberg, E.D. Iron availability and infection. Biochim. Biophys. Acta 2009, 1790, 600-605.
21. Antunes, L.C.; Imperi, F.; Towner, K.J.; Visca, P. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res. Microbiol. 2011, 162, 279-284.
22. Zimbler, D.L.; Penwell, W.F.; Gaddy, J.A.; Menke, S.M.; Tomaras, A.P.; Connerly, P.L.; Actis, L.A. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 2009, 22, 23-32.
23. Gaddy, J.A.; Arivett, B.A.; McConnell, M.J.; López-Rojas, R.; Pachón, J.; Actis, L.A. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 2012, 80, 1015-1024.
24. Mortensen, B.L.; Skaar, E.P. The contribution of nutrient metal acquisition and metabolism to Acinetobacter baumannii survival within the host. Front. Cell. Infect. Microbiol. 2013, 3, 95.
25. De Léséleuc, L.; Harris, G.; KuoLee, R.; Chen, W. In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob. Agents Chemother. 2012, 56, 5397-5400.
26. Antunes, L.C.; Imperi, F.; Minandri, F.; Visca, P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2012, 56, 5961-5970.
27. Minandri, F.; Bonchi, C.; Frangipani, E.; Imperi, F.; Visca, P. Promises and failures of gallium as an antibacterial agent. Future Microbiol. 2014, 9, 379-397.
28. Nucleo, E.; Steffanoni, L.; Fugazza, G.; Migliavacca, R.; Giacobone, E.; Navarra, A.; Pagani, L.; Landini, P. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009, 9, 270.
29. Smith, M.G.; Gianoulis, T.A.; Pukatzki, S.; Mekalanos, J.J.; Ornston, L.N.; Gerstein, M.; Snyder, M. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 2007, 21, 601-614.
30. Guterman, S.K. Colicin B: Mode of action and inhibition by enterochelin. J. Bacteriol. 1973, 114, 1217-1224.
31. Fournier, P.E.; Vallenet, D.; Barbe, V.; Audic, S.; Ogata, H.; Poirel, L.; Richet, H.; Robert, C.; Mangenot, S.; Abergel, C., et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006, 2, e7.
32. Iacono, M.; Villa, L.; Fortini, D.; Bordoni, R.; Imperi, F.; Bonnal, R.J.; Sicheritz-Ponten, T.; de Bellis, G.; Visca, P.; Cassone, A., et al. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob. Agents Chemother. 2008, 52, 2616-2625.
33. D'Arezzo, S.; Principe, L.; Capone, A.; Petrosillo, N.; Petrucca, A.; Visca, P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J. Antimicrob. Chemother. 2011, 66, 54-61.
34. Van Dessel, H.; Dijkshoorn, L.; van der Reijden, T.; Bakker, N.; Paauw, A.; van den Broek, P.; Verhoef, J.; Brisse, S. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 2004, 155, 105-112.
35. Ohman, D.; Sadoff, J.; Iglewski, B. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: Isolation and characterization. Infect. Immun. 1980, 28, 899-908.
36. O'Toole, G.; Kaplan, H.B.; Kolter, R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54, 49-79.
37. Jurcisek, J.A.; Dickson, A.C.; Bruggeman, M.E.; Bakaletz, L.O. In vitro biofilm formation in an 8-well chamber slide. J. Vis. Exp. 2011, 47, doi:10.3791/2481.
38. Sigma-Aldrich. Available online: www.sigmaaldrich.com (accessed on 14 August 2014).
39. Hider, R.; Xiaole, K.; Lucker, T.; Conlon, K.; Harland, R. SPD602 is a selective iron chelator which is able to mobilise the non-transferrin-bound iron pool. Blood 2013, 122, 1673.
40. Luo, G.; Spellberg, B.; Gebremariam, T.; Lee, H.; Xiong, Y.Q.; French, S.W.; Bayer, A.; Ibrahim, A.S. Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 845-851.
41. Lewis, R.E.; Pongas, G.N.; Albert, N.; Ben-Ami, R.; Walsh, T.J.; Kontoyiannis, D.P. Activity of deferasirox in Mucorales: Influences of species and exogenous iron. Antimicrob. Agents. Chemother. 2011, 55, 411-413.
42. Nisbet-Brown, E.; Olivieri, N.F.; Giardina, P.J.; Grady, R.W.; Neufeld, E.J.; Séchaud, R.; Krebs-Brown, A.J.; Anderson, J.R.; Alberti, D.; Sizer, K.C., et al. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: A randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 2003, 361, 1597-1602.
43. Vallenet, D.; Nordmann, P.; Barbe, V.; Poirel, L.; Mangenot, S.; Bataille, E.; Dossat, C.; Gas, S.; Kreimeyer, A.; Lenoble, P., et al. Comparative analysis of Acinetobacters: Three genomes for three lifestyles. PLoS One 2008, 19, e1805.
44. D'Andrea, M.M.; Giani, T.; D'Arezzo, S.; Capone, A.; Petrosillo, N.; Visca, P.; Luzzaro, F.; Rossolini, G.M. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2009, 53, 3528-3533.
45. Vaneechoutte, M.; Devriese, L.A.; Dijkshoorn, L.; Lamote, B.; Deprez, P.; Verschraegen, G.; Haesebrouck, F. Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J. Clin. Microbiol. 2000, 38, 4280-4281.
46. Zordan, S.; Prenger-Berninghoff, E.; Weiss, R.; van der Reijden, T.; van den Broek, P.; Baljer, G.; Dijkshoorn, L. Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany. Emerg. Infect. Dis. 2011, 17, 1751-1754.
47. MacKenzie, F.M.; Struelens, M.J.; Towner, K.J.; Gould, I.M.; ARPAC Steering Group; ARPAC Consensus Conference Participants. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin. Microbiol. Infect. 2005, 11, 938-954.
48. Towner, K.J.; Levi, K.; Vlassiadi, M.; on behalf of the ARPAC Steering Group. Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 2008, 14, 161-167.
49. Image J. Available online: http://rsbweb.nih.gov/ij/(accessed on 14 August 2014).
50. Miller, J.H. Experiments in Molecular Genetics; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, USA, 1972; pp. 252-255.